Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins

Expert Opinion on Drug Delivery

Volumn 7, Issue 10, 2010, Pages 1133-1144

  Rizwan, Shakila B ^a   Boyd, Ben J ^b   Rades, Thomas ^c   Hook, Sarah ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cubic phase; Cubosomes; Glycerylmonooleate; Liquid crystals; Peptides; Phytantriol; Proteins; Sustained delivery

Indexed keywords

GLYCEROL OLEATE; LIPID; PEPTIDE DERIVATIVE; PHYTANTRIOL; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

BILAYER MEMBRANE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; GEL; LIQUID CRYSTAL; MACROMOLECULE; PHYSICAL CHEMISTRY; REVIEW; SUSTAINED DRUG RELEASE;

DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GELS; GLYCERIDES; LIPIDS; LIQUID CRYSTALS; PEPTIDES; PROTEINS;

EID: 77957044587     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2010.515584     Document Type: Review

References (83)

1. Burbaum J, Tobal GM. Proteomics in drug discovery. Curr Opin Chem Biol 2002;6(4):427-433
2. Shi Y, Li L. Current advances in sustained-release systems for parenteral drug delivery. Expert Opin Drug Deliv 2005;2(6):1039-1058
3. Pauletti GM, Gangwar S, Knipp GT, et al. Structural requirements for intestinal absorption of peptide drugs. J Control Release 1996;41(1-2):3-17
4. Copland MJ, Rades T, Davies NM, Baird MA. Lipid based particulate formulations for the delivery of antigen. Immunol Cell Biol 2005;83:97-105
5. Watnasirichaikul S, Davies N, Rades T, Tucker I. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm Res 2000;17(6):684-689
6. Ericsson B, Eriksson PO, Lofroth JE, Engstrom S. Cubic phases as delivery systems for peptide drugs. In: Dunn RL, Ottenbrite RM, editors. Polymeric Drugs and Drug Delivery American Chemical Society Symposium Series. American Chemical Society, Washington; 1991. p. 251-265
7. Clogston J, Caffery M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acid. J Control Release 2005;107:97-111
8. Boyd B, Whittaker D, Khoo S, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm 2006;309:216-226
9. Rizwan SB, Hanley T, Boyd BJ, Hook S. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci 2009;98(11):4191-4204
10. Burrows R, Collett JH, Attwood D. The release of drugs from monoglyceride-water liquid crystalline phases. Int J Pharm 1994;111:283-293
11. Shah J, Sadhale Y, Chilukuri D. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229-250
12. Collings PJ. Liquid crystals natures delicate phase of matter. 2nd edition. Princeton University Press, Princeton, New Jersey; 2002
13. Hyde S. Identification of lyotropic liquid crystal mesophases, Chapter 16. In: Holmberg K, editor. Handbook of applied surface and colloid chemistry. John Wiley & Sons Ltd, New York; 2001. p. 299-331
14. Hyde S, Andersson A, Larsson K, et al. The language of shape. 1st edition. Elsevier, New York; 1997
15. Brown GH, Wolken JJ. Liquid crystals and biological structures. 1st edition. Academic Press, New York; 1979
16. Pratt L. Theory of hydrophobic effects. Annu Rev Phys Chem 1985;36:433-449
17. Kaasgaard T, Drummond CJ. Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent. Phys Chem Chem Phys 2006;8:4957-4975
18. Seddon JM, Templer RH. Polymorphism of lipid-water systems, Chapter 3. In: Lipowsky R, Sackmann E, editors. Handbook of biological physics. Elsevier Science, London; 1995. p. 97-160
19. Luzzati V. Biological significance of lipid polymorphism: the cubic phases. Curr Opin Struct Biol 1997;7:661-668
20. Lindblom G, Rilfors L. Cubic phases and isotropic structures formed by membrane lipids - possible biological relevance. Biochim Biophys Acta 1989;988:221-256
21. Seddon JM, Templer RH. Cubic phases of self-assembled amphiphilic aggregates. Philos Trans R Soc Lond A 1993;344(1672):377-401
22. Seddon JM. Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids. Biochim Biophys Acta 1990;1031:1-69
23. Luzzati V, Husson F. The structure of the liquid-crystalline phases of lipid-water systems. J Cell Biol 1962;12:207-219
24. Luzzati V, Tardieu A, Guilk-Kryzwicki T, et al. Structure of the cubic phases of lipid-water systems. Nature 1968;220(485):485-488
25. Fontell K, Mandell L, Ekwall P. Some isotropic mesophases in systems containing amphiphilic compounds. Acta Chem Scand 1968;22:3209-3223
26. Lutton ES. Phase behavior of aqueous systems of monoglycerides. J Am Oil Chem Soc 1965;42:1068-1070
27. Lindblom G, Larsson K, Johansson L, et al. The cubic phase of monoglyceride-water systems. Arguments for a structure based upon lamellar bilayer units. J Am Chem Soc 1979;101(19):5465-5470
28. Spicer P, Hayden K, Lynch ML, et al. Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir 2001;17(19):5748-5756
29. Amar-Yuli I, Libster D, Aserin A, Garti N. Solubilization of food bioactives within lyotropic liquid crystalline mesophases. Curr Opin Colloid Interface Sci 2009;14:21-32
30. Yang B, Armitage B, Marder S. Cubic liquid-crystalline nanoparticles. Agnre Chemie Int 2004;43:4402-4409
31. Rizwan SB, Dong Y, Boyd BJ, et al. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 2007;38(5):478-485
32. Drummond CK, Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci 2000;4:449-456
33. Clogston J, Craciun G, Hart DJ, Caffrey M. Controlling release from the lipidic cubic phase by selective alkylation. J Control Release 2005;102(2):441-461
34. Sjolund M, Lindblom G, Rilfors L, Arvidson G. Hydrophobic molecules in lecithin-water systems. I. Formation of reversed hexagonal phases at high and low water contents. Biophys J 1987;52(2):145-153
35. Rama Krishna YV, Marsh D. Spin label ESR and 31P-NMR studies of the cubic and inverted hexagonal phases of dimyristoylphosphastidylcholine/myristic acid (1:2, mol/mol) mixtures. Biochim Biophys Acta 1990;1024(1):89-94
36. Eriksson PO, Lindblom G. Lipid and water diffusion in bicontinuous cubic phases measured by NMR. Biophys J 1993;64(1):129-136
37. Fong C, Wells D, Krodkiewska I, et al. Synthesis and mesophases of glycerate surfactants. J Phys Chem B 2007;111:1384-1392
38. Hato M, Minamikawa H. The effects of oligo saccharide stereochemistry on the physical properties of aqueous synthetic lipids. Langmuir 1996;12:1658-1665
39. Larsson K. Cubic lipid-water phases: structures and biomembrane aspects. J Phys Chem 1989;93:7304-7314
40. Wyatt D, Dorschel A. A cubic-phase delivery system composed of glyceryl monooleate and water for sustained release of water-soluble drugs. Pharm Technol 1992;16(10):116-130
41. Chang C, Bodmeier R. Swelling of and drug release from monoglyceride-based drug delivery systems. J Pharm Sci 1997;86(6):747-752 (Pubitemid 27248827)
42. Larsson K. Lyotropic liquid crystals and their dispersions relevant in foods. Curr Opin Colloid Interface Sci 2009;14:16-20
43. Ganem-Quintanar A, Quintanar-Guerrero D, Buri P. Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm 2000;26(8):809-820
44. Dong Y, Larson I, Hanley T, Boyd BJ. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal structure. Langmuir 2006;22:9512-9518
45. Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstructures: beyond vesicles and liposomes. Nano Lett 2005;5:1615-1619
46. Barauskas J, Landh T. Phase behaviour of the phytantriol/water system. Langmuir 2003;19(23):9562-9565
47. Ribier A, Biatry B, inventors; LOreal, Paris, assignee. Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent. US 5756108; 1998
48. Boyd BJ, Whittaker DL, Khoo S, Davey G. Hexosomes formed from glycerate surfactants - formulation as a colloidal carrier for irinotecan. Int J Pharm 2006;318:152-162
49. Wadsten-Hindrichsen P, Bender J, Unga J, Engstrom S. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. J Colloid Interface Sci 2007;315:701-713
50. Lara MG, Bentley MV, Collet JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm 2005;293:241-250
51. Sadhale Y, Shah J. Biological activity of insulin in GMO gels and the effect of agitation. Int J Pharm 1999;191:65-74
52. Sadhale Y, Shah J. Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel. Int J Pharm 1999;191:51-64
53. Shah MH, Paradkar A. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. Int J Pharm 2005;294(1-2):161-171
54. Higuchi WI. Diffusional models useful in biopharmaceutics. J Pharm Sci 1967;56:315-324
55. Landau E, Rosenbusch J. Lipid cubic phases: a novel concept for the crystallization of membrane proteins. Proc Natl Acad Sci USA 1996;93:14532-14535
56. Caffery M. Crystallizing membrane proteins for structure determination: use of lipidic mesophases. Annu Rev Biophys 2009;38:29-51
57. Nollert P, Royant A, Pebay-Peyroula E, Landau EM. Detergent-free membrane protein crsytalization. FEBS Lett 1999;457(2):205-208
58. Engstrom S, Engstrom L. Phase behaviour of the lidocaine-monoolein-water system. Int J Pharm 1992;79(1-3):113-122
59. Engstrom S, Lindhal L, Wallin R, Engblom J. A study of polar lipid drug carrier systems undergoing a thermosensitive lamellar-to-cubic phase transition. Int J Pharm 1992;86:137-145
60. Lynch ML, Ofori-Boateng A, Hippe A, et al. Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants. J Colloid Interface Sci 2003;260:404-413
61. Wang Z, Zheng L, Inouue T. Effect of sucrose on the structure of a cubic phase formed from monoolein/water mixture. J Colloid Interface Sci 2005;288:638-641 (Pubitemid 40779569)
62. Nylander T, Mattisson C, Razumas V, et al. A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase. Colloid Surf A 1996;114:311-320
63. Zheng L, Zhang J, Shui L, et al. Component effects on the phase behavior of monoglyceride-water mixtures studied by FT-IR and X-ray diffraction. J Dispers Sci Technol 2003;24(6):773-778
64. Ericsson B, Larsson K, Fontell K. A cubic protein-monoolein-water phase. Biochim Biophys Acta 1983;729(1):23-27
65. Leslie S, Puvvada S, Ratna B, Rudolph A. Encapsulation of hemoglobin in a bicontinuous cubic phase lipid. Biochim Biophys Acta 1996;1285:246-254
66. Lopez BJA, Quintanar-Guerrero D, Romero RA, et al. Preliminary study: evaluation of glyceryl monooleate cubic phase as a protection and carrier system for Actinobacillus pleuropneumoniae toxins in mice. J Anim Vet Adv 2010;9(9):1311-1317
67. Caboi F, Amico GS, Pitzalis P, et al. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior. Chem Phys Lipids 2001;109(1):47-62
68. Shearman GC, Templer RH, Seddon JM. Inverse lyotropic phases of lipids and membrane curvature. J Phys Condens Matter 2006;18:S1105-24
69. Chang C, Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transformig into a highly viscous cubic phase. Int J Pharm 1998;173:51-60
70. Fong W-K, Hanley T, Boyd BJ. Stimuli responsive liquid crystals provide on-demand drug delivery in vitro and in vivo. J Control Release 2009;135(3):218-226
71. Landh T. Phase behavior in the system pine oil monoglycerides - poloxamer 407 - water at 20 C. J Phys Chem B 1994;98:8453-8467
72. Boyd BJ. Characterisation of drug release from cubosomes using the pressure ultrafiltration method. Int J Pharm 2003;260:239-247
73. Boyd BJ, Rizwan SB, Dong Y, et al. Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: hexosomes are not necessarily flat hexagonal prisms. Langmuir 2007;23(25):12461-12464
74. Tiberg F. Improving drug delivery by use of lipid self-assembly particle structures - beyond liposomes and emulsions. Business Briefing Pharma Outsourcing 2005:62-65 http://www.touchbriefings. com/cdps/cditem.cfm?NID=1133
75. Spicer P. Cubosomes: bicontinuous cubic liquid crystalline nanostructured particles. In: Nalwa H, editor. Encyclopedia of nanoscience and nanotechnology. Marcel Dekker, USA; 2004
76. Lopes LB, Ferreira DA, dePaula D, et al. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptide: in vitro and in vivo skin penetration of cyclosporin A. Pharm Res 2006;23(6):1332-1342
77. Spicer P. Progress in liquid crystalline dispersions: cubosomes. Curr Opin Colloid Interface Sci 2005;10:274-279
78. Johnsson M, Lam Y, Barauskas J, Tiberg F. Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate/glycerol dioleate mixtures. Langmuir 2005;21:5159-5165
79. Barauskas J, Johnsson M, Joabsson F, Tiberg F. Cubic phase nanoparticles (cubosome): principles for controlling size, structure, and stability. Langmuir 2005;21:2569-2577
80. Johnsson M, Barauskas J, Tiberg F. Cubic phases and cubic phase dispersions in a phospholipid-based system. J Am Chem Soc 2005;127:1076-1077
81. Barauskas J, Razumas V, Nylander T. Solubilization of ubiquinone-10 in the lamellar and bicontinuous cubic phases of aqueous monolein. Chem Phys Lipids 1999;97:167-179
82. Engstrom S. Cubic phases as drug delivery systems. Polymer Preprint 1990;31:157-158
83. Nirale N, Menon M. Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation. Indian J Pharm Sci 2010;72(1):65-71